Skip to content

Drug interactions

Maprotiline + Repaglinide

Severity: Minor

Maprotiline and Repaglinide: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Maprotiline may modestly alter glucose control and could add to the glucose-lowering effect of insulin secretagogues. Repaglinide can cause hypoglycemia, so a small additive effect is possible though rarely significant.

What this interaction means in plain words

Maprotiline and Repaglinide have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Maprotiline belongs to Central Nervous System; Repaglinide belongs to Endocrine.

Evidence level: Low

Why it happens

Possible additive pharmacodynamic effect on glucose homeostasis; the mechanism is not firmly established.

What to do

Monitor blood glucose when maprotiline is started or stopped and counsel the patient on hypoglycemia symptoms.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Maprotiline and Repaglinide, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Maprotiline with Repaglinide?

MediHelp rates the interaction as minor. Maprotiline and Repaglinide have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Maprotiline may modestly alter glucose control and could add to the glucose-lowering effect of insulin secretagogues. Repaglinide can cause hypoglycemia, so a small additive effect is possible though rarely significant.

How serious is the interaction between Maprotiline and Repaglinide?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood glucose when maprotiline is started or stopped and counsel the patient on hypoglycemia symptoms.

What other medicines interact with Maprotiline?

MediHelp also lists interactions of Maprotiline with, for example, Arsenic trioxide, Disopyramide, Dofetilide. The full list is on the Maprotiline page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in